About Praveen Tyle
Praveen Tyle is a director at Kiora Pharmaceuticals.
Form D filings name Praveen Tyle as a director at Gila Therapeutics.
Praveen Tyle reports to the SEC as a director or officer of 5 public companies, including Skye Bioscience (SKYE), Lexicon Pharmaceuticals (LXRX) and Gi Dynamics.
Praveen Tyle first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Praveen Tyle in the role, so the role may have started earlier or lasted longer.
KI
Kiora Pharmaceuticals Inc.
Director
2015 – 2026 · Public company (KPRX)
SI
Skye Bioscience, Inc.
Director
2021 – 2024 · Public company (SKYE)
LI
Lexicon Pharmaceuticals, Inc.
EVP, R&d
2016 – 2021 · Public company (LXRX)
GI
Gi Dynamics, Inc.
Director
2020 · Public company
BI
Bausch & Lomb Inc.
Senior Vice President
2006 – 2007 · Public company (BOL)
Key Colleagues at Startups
The people Praveen Tyle works with at each company, as listed on that company's latest Form D.
Gila Therapeutics, Inc. · Form D, Dec 6, 2023
TB
Timothy Barberich
Director
CS
Christopher De Souza
Director
JF
Jon Freeman
Executive officer
TV
Thomas Vasicek
Executive officer
RH
Richard Horan
Director
SS
Scott Schorer
Cief Executive Officer and director
SK
Sangeeta Kashyap
Executive officer